GE HealthCare Technologies Inc. $GEHC Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 43.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,386 shares of the company’s stock after selling 9,662 shares during the quarter. Securian Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $1,016,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Temasek Holdings Private Ltd acquired a new stake in GE HealthCare Technologies in the third quarter valued at approximately $99,922,000. Locust Wood Capital Advisers LLC lifted its position in shares of GE HealthCare Technologies by 7.1% during the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after purchasing an additional 137,992 shares in the last quarter. Nan Fung Trinity HK Ltd. purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at $23,206,000. Envestnet Asset Management Inc. boosted its stake in shares of GE HealthCare Technologies by 15.8% in the third quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock valued at $25,452,000 after purchasing an additional 46,231 shares during the period. Finally, Sound Shore Management Inc CT grew its holdings in GE HealthCare Technologies by 14.6% during the 3rd quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company’s stock valued at $73,655,000 after purchasing an additional 125,062 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC opened at $62.29 on Wednesday. The company has a market capitalization of $28.34 billion, a P/E ratio of 14.90, a PEG ratio of 1.39 and a beta of 0.74. The company has a 50-day moving average of $70.62 and a 200-day moving average of $77.06. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

Analyst Ratings Changes

GEHC has been the topic of several analyst reports. Rothschild & Co Redburn dropped their price target on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Wells Fargo & Company lowered their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Piper Sandler cut their price target on GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Barclays reduced their price target on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a report on Thursday, April 30th. Finally, Mizuho dropped their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus target price of $80.67.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CFO James Saccaro acquired 3,310 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was purchased at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the acquisition, the chief financial officer directly owned 87,471 shares in the company, valued at $5,300,742.60. This trade represents a 3.93% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Watkin Phoebe L. Yang bought 1,000 shares of the stock in a transaction on Friday, May 8th. The shares were acquired at an average price of $63.01 per share, with a total value of $63,010.00. Following the purchase, the director owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 10,229 shares of company stock valued at $619,190 over the last 90 days. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.